| 中文摘要 |
卵巢癌常為晚期疾病，復發率高，一旦復發，如能早期診斷及早治療，可改善預後。傳統上，復發病灶多以婦檢、血清CA125、電腦斷層來追蹤檢測。最近，使用正子攝影或將其合併電腦斷層，輔以代謝性參數，可增加復發性卵巢癌第二次減積術的成功率，延長患者無症狀生存時間。
Ovarian cancer often presents at an advanced stage with frequent relapse despite optimal treatment, thus, accurate restaging is required for improving treatment outcomes and prognosis. Conventionally, detection of recurrent lesions is performed by using gynecologic examination, serum CA125(cancer antigen-125), computed tomography(CT) and magnetic resonance imaging(MRI). Recently, positron emission tomography(PET) or PET/CT, in addition to metabolic biomarkers, are found to be associated with improvement of optimal secondary surgery and progression-free survival in patients with recurrent ovarian cancer. |
本站僅提供期刊文獻檢索。
